Table 1 Overview of variants and rationale for testing in accessory assays

From: A functional assay–based procedure to classify mismatch repair gene variants in Lynch syndrome

Gene

Protein varianta

IARC class (InSiGHT)b

Prior-P (in silico)c

MMR activity (%)d

IARC class (two-component)

Rationale for Y2H and localization testing

Binding partner interactione

Nuclear localizationf

MLH1

Wild type

NA

NA

100

NA

 

+

+

p.R265S

4

0.884

27.0

4

(Likely) pathogenic

+

+

p.A608D

4

0.9

37.3

4

-

+

p.R659L

5

0.850

33.8

4

-

-

p.N64Sg

3

0.718

51.6

3

Uncertain

-

+

p.E268G

1

0.709

67.0

3

+

+

p.A619P

4

0.273

37.5

3

-

+

p.Q701K

2

0.1

72.7

1

Reduced activity in CIMRA assay

+

+

p.N710D

1

0.1

60.4

2

+

+

p.D132H

1

0.868

97.0

2

Discordant Prior-P/CIMRA

+

+

p.P581L

2

0.9

96.9

2

+

+

p.P603R

2

0.872

97.0

2

+

+

p.K618T

1

0.9

36.1

4

Discordant InSiGHT/two component

-

+

p.A681T

5

0.1

73.6

1

 

+

+

MSH2

Wild type

NA

NA

100

NA

 

+

+

p.Q419K

2

0.1

97.2

1

(Likely) not pathogenic

+

+

p.A834T

2

0.428

90.1

1

+

+

p.L93F

4

0.691

50.5

3

Uncertain

+

+

p.Y165D

4

0.182

10.7

3

+

-

p.N331D

2

0.757

62.4

3

+

+

p.R524Lg

3

0.852

59.5

3

+

+

p.I577T

2

0.325

54.8

3

+

+

p.P652H

4

0.665

72.5

3

+

+

p.T8M

1

0.1

60.1

2

Reduced activity in CIMRA assay

+

+

p.R96H

2

0.1

69.5

1

+

+

p.R106K

1

0.1

80.3

1

+

+

  1. CIMRA cell-free in vitro MMR activity, IARC International Agency for Research on Cancer.
  2. aAmino acid numbering is based on the cDNA with +1 corresponding to the translation initiation codon in the GenBank reference sequence. MLH1: NP_000240.1; MSH2: NP_000242.1.
  3. bIARC classification for each variant as classified by the InSiGHT Variant Interpretation Committee.
  4. cIn silico prior probabilities as previously calculated,11 truncated at a minimum value of 0.1 and a maximum value of 0.9.
  5. dCIMRA assay values as determined experimentally in this work.
  6. eBinding partner interaction (either MLH1 binding to PMS2 or MSH2 binding to MSH6) as determined by Y2H assays.+ Proficient for interaction, - deficient for interaction.
  7. fNuclear localization of MMR proteins as determined by transfections of fluorescently tagged proteins combined with microscopy. +Proficient for nuclear localization, - deficient for nuclear localization.
  8. gVariant reclassified by InSiGHT to class 3 (Uncertain) after our experiments were completed.